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System, School of Medicine, Charlottesville, VA, USA.Neuropathic pain is a severe health problem for which there is a lack of effective therapy. A frequent
underlying condition of neuropathic pain is a sustained overexcitability of pain-sensing (nociceptive)
sensory ﬁbres. Therefore, the identiﬁcation of mechanisms for such abnormal neuronal excitability is
of utmost importance for understanding neuropathic pain. Despite much effort, an inclusive model
explaining peripheral overexcitability is missing. We investigated transcriptional regulation of the Kcnq2
gene, which encodes the Kv7.2 subunit of membrane potential-stabilizing M channel, in peripheral sen-
sory neurons in a model of neuropathic pain—partial sciatic nerve ligation (PSNL). We show that Kcnq2 is
the major Kcnq gene transcript in dorsal root ganglion (DRG); immunostaining and patch-clamp record-
ings from acute ganglionic slices veriﬁed functional expression of Kv7.2 in small-diameter nociceptive
DRG neurons. Neuropathic injury induced substantial downregulation of Kv7.2 expression. Levels of
repressor element 1–silencing transcription factor (REST), which is known to suppress Kcnq2 expression,
were upregulated in response to neuropathic injury identifying the likely mechanism of Kcnq2 regulation.
Behavioural experiments demonstrated that neuropathic hyperalgesia following PSNL developed faster
than the downregulation of Kcnq2 expression could be detected, suggesting that this transcriptional
mechanism may contribute to the maintenance rather than the initiation of neuropathic pain. Impor-
tantly, the decrease in the peripheral M channel abundance could be functionally compensated by
peripherally applied M channel opener ﬂupirtine, which alleviated neuropathic hyperalgesia. Our work
suggests a novel mechanism for neuropathic overexcitability and brings focus on M channels and REST
as peripheral targets for the treatment of neuropathic pain.
 2010 International Association for the Study of Pain. Published by Elsevier B.V.
Open access under CC BY license.1. Introduction
Nerve injury or degeneration often results in the development
of neuropathic pain. This type of pain constitutes an enormous
health problem because it is particularly difﬁcult to treat with con-
ventional analgesics. Often neuropathic pain is caused by the
unprovoked and uncontrolled activity of peripheral nerve ﬁbres
[11]; the search for the mechanisms of such peripheral overexcit-
ability is ongoing, but a clear picture remains elusive.
When peripheral sensory ﬁbres are severed, the proximal part
of the nerve forms a terminal swelling or endbulb, which may then
form a neuroma [11,14]. Both the neuroma and the cell bodies of
damaged nerves generate anomalous ectopic ﬁring [2,15,27,51],
with inﬂammation [38], sympathetic sprouting [9,30] and changestudy of Pain. Published by Elsevie
brane and Systems Biology,
niversity of Leeds, LS2 9JT
3 3167.
).
University of Virginia Healthin the expression of various genes related to neuronal excitability
[53] being identiﬁed as likely contributing factors.
One of the major mechanisms controlling tonic excitability of
mammalian neurons is M-type K+ current [7] conducted by Kv7
channels (encoded by the Kcnq1-5 genes). In neurons most M chan-
nels are formed by homomeric or heteromeric association of Kv7.2,
Kv7.3, and Kv7.5 [10,52]. Because of their distinctive biophysical
properties (slow activation and deactivation, no inactivation, and
a threshold for activation below 60 mV), M channel activity
maintains strong control over neuronal excitability. Genetic deﬁ-
ciency or acute inhibition of M channels in neurons leads to over-
excitability (eg, seizures), whereas M channel openers have an
antiexcitatory effect [10]. Recently functional M channels were
identiﬁed in sensory neurons [25,26,36]. Moreover, it has been
demonstrated that acute inhibition of M channels in nociceptors
causes depolarization, increases excitability, and produces nocifen-
sive behaviour in rats [25,26].
Recently we demonstrated that Kcnq genes have functional
repressor element 1 (RE1) binding sites that are able to recruit
repressor element 1–silencing transcription factor (REST, alsor B.V. Open access under CC BY license.
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tion of Kcnq transcription [32]. Thus, overexpression of REST in
dorsal root ganglia (DRG) neurons robustly suppressed M current
density and increased tonic excitability of these neurons [32].
Baseline REST expression in neurons is low, but it was shown to
increase greatly after inﬂammation [32] or after the neuropathic
injury [49]. Thus, we hypothesized that transcriptional downregu-
lation of Kcnq gene expression by REST may contribute to neuro-
pathic hyperexcitability of DRG neurons. To test this concept we
characterised expression of Kcnq genes in DRG and studied tran-
scriptional regulation of the major Kcnq transcript, Kcnq2, in an
animal model of neuropathic pain. We show that the expression
of Kcnq2 is strongly suppressed in DRG after neuropathic injury,
an effect most likely mediated by REST as its nuclear expression
in neurons was upregulated. Because M channels maintain neuro-
nal resting membrane potential, Kcnq2 downregulation would con-
tribute to ectopic activity of neuropathic ﬁbres. Accordingly,
application of the M channel opener ﬂupirtine directly to the site
of injury reduced neuropathic hyperalgesia. Our ﬁndings describe
a novel mechanism contributing to peripheral sensitization after
nerve injury, reinforce Kv7 channels as a peripheral drug target
for treatment of pain, and identify REST as a potential novel target
in pain therapeutics.
2. Materials and methods
2.1. Acute DRG slice preparation
DRGs were sliced in accordance with Scholz et al. [42]. Brieﬂy,
DRGs were embedded in liquid 2% w/v agar and sectioned (all steps
on ice) with a vibroslicer (Leica VT1000S, Leica Microsystems,
Nussloch GmbH, Germany) at 190 lm thick in artiﬁcial cerebrospi-
nal ﬂuid solution (in mM; 124 NaCl, 26 NaHCO3, 10 glucose, 3 KCl,
2 MgSO4, 2.5 NaH2PO4, 2 CaCl2) that was bubbled with carbogen.
No enzymatic treatment was used during the acute slice prepara-
tion of DRG and during the subsequent patch clamp recording.
2.2. Electrophysiology
An amphotericin B perforated patch was used for patch clamp
recordings as described elsewhere [25]. The intracellular pipette
solution contained (in mM): 140 KCl, 1 MgCl2, 10 HEPES, 10 EGTA,
1 CaCl2; artiﬁcial cerebrospinal ﬂuid solution (see earlier) was used
as extracellular solution. The recordings were made using EPC-10
ampliﬁer and Patchmaster 2.2 software (both from HEKA Elektro-
nik, Lambrecht, Germany). To evaluate the amplitude of M current,
DRG neurons were held at 30 mV, and 1-second hyperpolarising
steps to 60 mV followed by a 1-second step to 30 mV, were ap-
plied every 3 seconds.
2.3. Animals
Adult (150 to 200 g) male Wistar rats (bred in-house) were used
for this study. Rats were housed in the University of Leeds Animal
facility in groups of 4 on a 12:12 light–dark schedule. Food and
water were available ad libitum. After delivery, rats were main-Table 1
Primary and secondary antibody information.
Primary antibody Dilution Reference/supplie
Rabbit anti-Kv7.2 1:2000 Roche et al. [39]
Rabbit anti-REST 1:500 Santa Cruz
Mouse anti-NF200 1:1000 Sigma
Biotinylated IB4 1:1000 Sigma
Guineapig anti-TRPV1 1:1000 Neuromics
Cy3-conjugated anti-GFAP 1:500 Sigmatained within the in-house animal facility for at least 2 days before
surgery or behavioural testing. All experimental procedures on ani-
mals followed the guidelines and recommendations of the UK
Home Ofﬁce and were in accordance with the regulations of the
UK Animals (Scientiﬁc procedures) Act 1986.
2.4. Partial sciatic nerve ligation (PSNL) surgery
Partial ligation of the left sciatic nerve was performed as previ-
ously described [43]. Brieﬂy, male Wistar rats (150 to 200 g) were
anesthetised with 2% v/v isoﬂurane; the left sciatic nerve was ex-
posed at mid-thigh level and cleared of surrounding connective tis-
sues. A 6-0 Prolene suture (Ethicon Ltd. Edinburgh, UK) was
inserted into the nerve with a 3/8 curved, reversed-cutting mini-
needle, and tightly ligated so that the dorsal third/half of the nerve
was held within the ligature. A small cut was made approximately
5 mm below the ligature. The wound was then closed using 2 to 5
skin clips (Reﬂex, Harward Apparatus, Kent, UK). In sham-operated
rats, the left sciatic nerve was exposed but untouched.
2.5. Peri-sciatic nerve injection
Lidocaine (0.65% v/v) and M channel modulators ﬂupirtine
(50 lM) and XE991 (10 lM) were injected in a volume of 200 lL
to the area surrounding the sciatic nerve to directly deliver drugs
to the neuroma site. The concentration of lidocaine used in this
study was based on Ma et al. [29]; concentrations of the XE991
and ﬂupirtine were based on Wang et al. [52] and Luisiet al. [28],
respectively. Rats were brieﬂy anaesthetised with isoﬂurane (until
tail pinch reﬂex was absent but eye blink reﬂex remained). The
needle was inserted into the left thigh until it made contact with
the thigh bone and then brought back few millimetres, and solu-
tion was injected gradually over 3 seconds.
2.6. Thermal hyperalgesia (Hargreaves test)
Change in withdrawal latency to noxious heat was recorded
using the Hargreaves plantar method [19] (UgoBasile, Stoelting,
Italy). Rats were acclimated for at least 20 minutes before the test.
The heat source was placed directly under the plantar surface of
the hind paw, and the latency of paw withdrawal (in seconds)
was measured with automated digital timer. Pre-surgery thermal
latency values were recorded between 1 and 4 days before PSNL in-
jury or sham surgery. During these baseline recordings the infrared
intensity was adjusted with a constant voltage power supply to ob-
tain a baseline response time of approximately 12 seconds, and the
same settings were used throughout the whole series. Both ipsilat-
eral and contralateral hind paw withdrawal latencies were re-
corded 15 and 30 days after surgery.
2.7. Mechanical hyperalgesia (Randall-Selitto algesymeter paw-
withdrawal test)
The nociceptive ﬂexion reﬂex was quantiﬁed with an Ugo Basile
Analgesymeter 37215, which applies a linearly increasing mechan-
ical force to the dorsum of the rat hind paw [37]. The mechanicalr Secondary antibody Supplier
Donkey anti-rabbit Alexa 555/488 Invitrogen
Donkey anti-rabbit Alexa 555 Invitrogen
Donkey anti-mouse Alexa 488 Invitrogen
Streptavidin-conjugated Alexa 488 Invitrogen
Goat anti-guinea pig Alexa 488 Invitrogen
N/A N/A
Fig. 1. Expression of Kv7.2 in DRG neurons. (A) Confocal micrographs at 40 (a and
b) and 10 (c and d) magniﬁcation of DRG sections stained with anti-Kv7.2
antibody (a–c), or no-primary control (d). Nuclei were stained with DAPI (d). Scale
bars = 50 lm. (B) The cell diameter of Kv7.2-positive neurons within L4 DRG was
measured to the nearest micrometer and is presented as a frequency distribution.
(C) Kv7.2 immunoreactivity was not detectable within satellite glial cells (SGC) of
DRG. Confocal micrographs for immunostaining with antibodies against the glial
marker GFAP (a); Kv7.2 (b); co-staining (c) and no-primary control (d). Scale
bars = 50 lm.
Fig. 2. Colocalization of Kv7.2 and IB4 in small DRG neurons. Confocal micrographs
for immunostaining with antibodies against the nonpeptidergic nociceptive neuron
marker IB4 (a); Kv7.2 (b); co-staining (c and e), and no-primary control (d). Scale
bars = 50 lm. Examples of co-staining are indicated with arrows.
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the rat withdrew its hind paw. Rats were acclimated for at least20 minutes before the test. Mechanical thresholds were recorded
as the mean of 3 measurements at 10-minute intervals. Baseline
mechanical thresholds were established between 0 and 4 days be-
fore surgery. Behavioural testing resumed 15 and 30 days after
surgery.
2.8. DRG and sciatic nerve removal
Rats were killed by schedule 1 technique in accordance with
Home Ofﬁce guidance. A laminectomy of the lumbar region was
carried out. Scissors were used to cut the lamina and body of the
spinal vertebrates until the left and right sides of the column were
separated. The spinal cord and meninges were then carefully re-
moved to allow removal of DRG. After removal of DRG, any at-
tached nerves were cut and then DRGs were prepared for reverse
transcriptase–polymerase chain reaction (RT-PCR), Western blot,
or immunohistochemistry as described later. To excise sciatic
nerve, the skin overlying the thigh was removed and muscles over-
lying the nerve were separated using large scissors at the mid-
thigh level. Approximately a 1 cm length of sciatic nerve was cut
at mid-thigh height and used for immunohistochemical studies.
Fig. 3. Colocalization of Kv7.2 and TRPV1 in small DRG neurons. Confocal
micrographs for immunostaining with antibodies against the nociceptive neuron
marker TRPV1 (a); Kv7.2 immunostaining (b), co-staining (c and e), and for no-
primary control (d). Scale bars = 50 lm. Examples of co-staining are indicated with
arrows. Fig. 4. Colocalization of Kv7.2 and NF200 in DRG neurons. Confocal micrographs for
immunostaining with antibodies against Kv7.2 (a); large mechanosensitive DRG
neuron marker NF200 (b), co-staining (c and e), and for no-primary control (d).
Scale bars = 50 lm. Examples of co-staining are indicated with arrows.
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Total RNA was extracted from homogenised L4/L5 DRG using
Quiazollysis reagent (Qiagen, Crawley, UK). Contaminating DNA
was removed using a DNA-free kit (Applied Biosystems, Warring-
ton, UK). RNA was reverse transcribed using M-MLV reverse trans-
criptase (Promega, Southampton, UK) per manufacturer’s protocol.
Resulting cDNA was puriﬁed using a QIAquick PCR puriﬁcation kit
(Qiagen, Crawley, UK). Quantitative RT-PCR was performed on a
MyIQ Real-time RT-PCR detection system (BioRAD, Hemel Hemp-
stead, UK). For each primer set, water and no RT RNA samples were
used in place of a template as negative controls. The following
primers were used: Kcnq2 sense 50-CCGGCAGAACTCAGAAGAAG;
Kcnq2 antisense 50-TTTGAGGCCAGGGGTAAGAT; Rest sense 50-CGA
ACTCACACAGGAGAACG; Rest antisense 50-GAGGCCACATAATTGC
ACTG; U6 sense 50-CTCGCTTCGGCAGCACA; U6 antisense 50-AACGC
TTCACGAATTTGCGT. SYBR green was used as a reporter. The cycle
at which ﬂuorescence increases above background (threshold
cycle, Ct) was measured during the exponential phase of the PCR.
Expression levels of genes were normalized to those of U6.2.10. Western blot
Protocol used for nuclear-enriched preparation of L4/L5 DRG
neurons was adapted from Berti-Mattera et al. [5]. Brieﬂy, DRGs
were homogenised on ice in hypotonic buffer (in mM; 10 HEPES,
pH 7.9, 10 KCl, 10 EDTA, 1 DTT, 0.3% Tirton-X v/v, 57 mOsm, sup-
plemented with protease inhibitor tablet [Roche, West Sussex,
UK]). Nuclei were pelleted by centrifugation at 9000g for 5 minutes
at 4C. The resulting supernatant (cytosolic fraction) was removed
and stored at80C. The pellet was resuspended in high-salt buffer
(in mM; 20 HEPES, pH 7.9, 400 NaCl, 1 EDTA, 10% glycerol v/v, 1
DTT, 2.5 Osm, supplemented with protease inhibitor tablet) and
placed on a rocker at 4C for 2 hours. Cell debris was pelleted by
centrifugation at 9000g for 5 minutes at 4C. The supernatant
was the nuclear-enriched fraction. For total protein extraction of
kidney and forebrain, rough tissue homogenate was placed into a
glass–glass homogeniser and 50 lL RIPA buffer (50 Tris–HCl, pH
7.4, 150 NaCl, 1 EDTA, 1% v/v Triton-X v/v, 1% v/v sodium deoxy-
cholate, 0.1% w/v SDS, supplemented with protease inhibitor
Fig. 5. Expression of Kv7.2 within the sciatic nerve. Confocal micrographs for immunostaining of rat sciatic nerve with antibodies against Kv7.2 (a); large mechanosensitive
DRG neuron marker NF200 (b), co-staining (c and e) and no-primary control (d). Scale bars = 50 lm.
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freeze-thawed between dry ice and 37C water bath and centri-
fuged 9000g for 10 minutes at 4C. The protein samples were then
analysed using SDS-PAGE Western blot using standard protocol.
REST, b-actin, and Nup62 were detected using rabbit anti-REST
(Upstate/Millipore, Chicago, IL; 1:1000) mouse anti-b-actin, (Sig-
ma, York, UK 1:10000) and mouse anti-Nup62 (ProteinTech Group,
Inc. Manchetser, UK; 1:1000) antibodies, respectively. Nikon Ele-
ments AR 3.0 (Nikon UK Ltd., Kensington upon Thames, UK) soft-
ware was used to quantify signal intensities. The REST intensity
was normalized to that of Nup62 for each protein sample.
2.11. Immunohistochemistry
The standard immunohistochemical protocol requires ﬁxation
of the tissue section, which provides mechanical stability and anti-
gen retention within the tissue preparation. However, in the pres-
ent study ﬁxation of tissue sample caused a loss of antigen
speciﬁcity and nonspeciﬁc binding of the Kv7.2 antibody (gift of
Prof. Mark S Shapiro, UTHSCSA, USA; the antibody has been char-
acterized in Roche et al. [39]). Thus a fresh-frozen tissue prepara-
tion was used. The L4 DRGs or sciatic nerve were removed and
embedded in Tissue-Tek (optimal cutting temperature [OCT] solu-
tion, Leica Microsystems, Milton Keynes, UK) on dry ice. Cryostat
sections (10- to 25-lm slices) were thaw-mounted on slides
coated with poly-L-lysine and gelatine, and stored at 20C. Once
mounted, slices were incubated in phosphate-buffered saline (PBS)
for 5 minutes and then in PBS, 0.1% Triton-X for a further 10 min-
utes at room temperature. Slices were then rinsed in PBS for 3  5
minutes at room temperature and incubated in primary antibodies
(dilutions listed in Table 1) overnight at 4C. After primary anti-
body incubation, slices were washed in PBS for 3  5 minutes at
room temperature. Slices were then incubated with appropriate
secondary antibody (dilutions listed in Table 1) for 3 hours at room
temperature. For co-labeling studies, incubation with neurochem-
ical marker always preceded Kv7.2 labeling. Slides were then
mounted using Vectashield plus DAPI (Vector Laboratories, Burlin-game, CA). For each staining procedure, PBS without primary anti-
body was used as a negative control where cells were detected by
the presence of DAPI staining. When tissue samples from naive,
sham-operated, and PSNL animals were prepared for the purpose
of the comparison, each tissue sample was sliced consecutively
into 8 slices and each slice was mounted onto the separate glass
slide; this was done to enable mounting of individual tissue slices
from the contralateral and ipsilateral sides of the sham and PSNL
animals onto the same slide (so that the staining and imaging con-
ditions were identical for each series). A similar slicing protocol
was used for colocalization studies so that the repeats of a tissue
sample on the same slide were separated by at least 80 lm to
avoid labelling of same cells for averaging numbers per DRG. Con-
focal microscopy was performed with a Zeiss LSM 510 Meta micro-
scope (Carl Zeiss, Welwyn Gardens, Herts, UK); all settings were
adjusted at the beginning of the session and were not altered
throughout the session. Images were analysed using Nikon Ele-
ments AR 3.0 (NIS) software.
2.12. Statistical analysis
All data were assessed for normality using the Kolmogorov–
Smirnov normality test. Where data were not normally distributed,
Kruskal–Wallis one-way analysis of variance (ANOVA) on Ranks
was used with Dunn’s multiple comparison procedure. Where data
were normally distributed, one-way ANOVA with Holm–Sidak
multiple comparison procedure or Student’s t-test were used as
appropriate. Statistical analyses were performed with SigmaStat
3.1 software package (Systat Software Inc., Richmond, CA).
3. Results
3.1. Expression of functional Kv7 channels in DRG neurons
M channels in DRG neurons are formed by Kv7.2, Kv7.3, and
Kv7.5 subunits [36]; thus, we ﬁrst analysed relative expression of
Kcnq2, Kcng3, and Kcnq5 mRNAs in whole DRG lysates using
Fig. 6. M current recording from acute DRG slices. (A) Perforated patch recording of
M-like current from a small-diameter neuron in an acute DRG slice in the absence
(basal) or presence (XE991) of 3 lM XE991; voltage protocol is depicted earlier. (B)
Time course of M current inhibition by 3 lM XE991 (black bar) during a DRG slice
recording. (C) Comparison of M current density in individual neurons from P7
(black) and adult (red) rat DRG slices recorded at 30 mV in the absence (basal) or
presence of XE991 (⁄P < .05).
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mRNA (normalised to the level of housekeeping gene U6) were
0.31 ± 0.05 (n = 6), 0.07 ± 0.01 (n = 6), and 0.002 ± 0.001 (n = 7),
respectively. Thus, relative Kcnq2 mRNA expression was approxi-
mately 4-fold greater than that of Kcnq3 (P 6 .05) and 180-fold
greater than that of Kcnq5 (P 6 .01); we therefore focused our
study on Kcnq2.
Immunostaining of DRG sections (Fig. 1) demonstrated robust
expression of Kv7.2 in neurons of predominantly small diameter
(20.2 ± 0.3 lm, n = 547) (Fig. 1A and B). Both cell bodies and axonal
sprouts of DRG neurons displayed Kv7.2 expression (Fig. 1A). Kv7.2
immunoreactivity did not colocalize with glial marker glial ﬁbril-
lary acidic protein (GFAP) (Fig. 1C). In contrast, Kv7.2 staining
was colocalized with the markers of nociceptive neurons IB4
(Fig. 2) and TRPV1 (Fig. 3). Of the Kv7.2-positive neurons, 32.8 ±
2.6% were IB4-positive (829 neurons/4 rats) and 47.0 ± 4.9% were
TRPV1-positive (687 neurons/4 rats). In contrast, only 12.4% of
Kv7.2-positive neurons were positive for a marker of large, mech-
anosensitive neurons, NF200 (Fig. 4). Thus, Kv7.2 is predominantly
expressed in small-diameter nociceptive neurons within rat DRG.Staining of the sciatic nerve also revealed abundant Kv7.2 immu-
noreactivity (Fig. 5), which as in the case for DRG cell bodies
showed poor colocalization with NF200, suggesting there is limited
Kv7.2 expression within the larger-diameter DRG neuron ﬁbres
[41].
To verify that Kcnq2 expression results in the formation of func-
tional M channels in native DRG tissue, we performed perforated
patch-clamp recordings from acute L4/L5 DRG slices from newborn
(P7) or adult rats (Fig. 6). Slow-inactivating M-like currents that
were sensitive to speciﬁc M channel blocker XE991 (3 lM) were
recorded from small (cell capacitance of 16 ± 2 pF) DRG neurons.
The satellite glial cells that ensheath adult DRG are very rigid, mak-
ing recording from adult DRG neurons from acute slices technically
difﬁcult (to our knowledge no adult DRG slice recordings of M cur-
rent have been reported to date), thus we only obtained 3 such
recordings (from more than 10 rats) although these recordings
were consistent with those from newborn DRGs (Fig. 6C, red). In
neurons from newborn rats, 3 lM XE991 inhibited 26.6% ± 4.1%
(2.1 ± 0.4 pA/pF) of total outward current at 30 mV (8.9 ± 1.8
pA/pF, n = 7) and 10 lM XE991 inhibited 60.0% ± 15.9% of outward
current at30 mV (n = 3). Because high concentrations (100s lM)
of XE991 can block HERG channels [13], we applied XE991
(3 lM) in the presence of the HERG blocker terfenadine (1 lM).
When HERG channels were blocked with terfenadine, XE991 still
inhibited the outward current by 2.5 ± 1.1 pA/pF (n = 4; data not
shown), suggesting that the M-like current was not HERG but in-
deed M current. The deactivating current at 60 mV best ﬁt to a
double exponential function that gave fast and slow time constants
of 18 ± 4 ms and 249 ± 45 ms, respectively (within the range of val-
ues previously reported for Kv7.2 [35]). All recorded neurons re-
sponded to 1 lM capsaicin (not shown). These data represent the
ﬁrst electrophysiological characterization of M current in acute
DRG tissue; taken together, evidence presented in this section sug-
gests that: (1) Kcnq2 is the predominant Kcnq transcript in DRG, (2)
Kv7.2 forms functional M channels in DRG, and (3) many Kv7.2-
expressing neurons are nociceptors.
3.2. Transcriptional downregulation of Kcnq2 expression after
neuropathic injury
The experiments in this section were based on the following
previous ﬁndings: (1) neuropathic injury is often characterized
by the sustained overexcitability of peripheral nociceptors [11];
(2) acute inhibition of M current in nociceptive neurons by inﬂam-
matory mediators produces short-term excitability and acute pain
[25,26]; (3) neuropathic injury induces a large-scale remodelling of
nociceptive neurons driven by long-term changes in gene expres-
sion [53]. Thus we reasoned that because acute M channel
inhibition in DRG causes short-term excitability, long-term hyper-
excitability observed in some neuropathic pain conditions can be
in part caused by the downregulation of M channel expression.
Therefore we used quantitative RT-PCR to test whether the expres-
sion of Kcnq2 is regulated in an animal model of neuropathic injury
— PSNL. To minimize the contribution of acute trauma and postop-
erational inﬂammation, samples were taken 15 and 30 days
postsurgery (see later for the behavioural manifestations of neuro-
pathic trauma at these time intervals). Fifteen days postsurgery,
relative Kcnq2 mRNA expression levels (normalized to U6) in ipsi-
lateral and contralateral L4/L5 DRG from sham and PSNL rats were
not signiﬁcantly different from the Kcnq2 mRNA level in naïve rats
(n = 6, Fig. 7A). Thirty days after injury, the Kcnq2 mRNA levels in
ipsilateral DRG of neuropathic animals decreased to 0.09 ± 0.03
(n = 8) as compared with values of 0.31 ± 0.05 (n = 6) in naive
and 0.23 ± 0.05 (n = 7) in sham controls (P < .05). Additionally there
was a tendency of Kcnq2 mRNA to decrease in the contralateral
DRG of PSNL rats as well, but it did not reach signiﬁcance
Fig. 7. Reciprocal changes in Kcnq2 and Rest mRNA after peripheral nerve injury. Relative Kcnq2 (A) and Rest (B) mRNA levels in naive, sham-operated, and PSNL animals 15
and 30 days after surgery. All data are normalised to levels of the house keeping gene, U6. Differences were analysed using Kruskal–Wallis one-way analysis of variance on
ranks, multiple comparisons versus control group (Dunn’s method; ⁄P < .05, nP 6).
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experimental groups (not shown).
Kcnq gene expression is negatively regulated by the transcrip-
tional repressor REST. Thus, it was shown that a functional RE1 site
within Kcnq2 can physically interact with REST, which results in
suppression of Kcnq2 expression [32]. Accordingly, overexpression
of REST in DRG neurons led to a prominent decrease in Kcnq2
mRNA level, Kv7.2 protein level, and M current density and re-
sulted in hyperexcitable neurons [32]. We therefore tested
whether Rest expression is changed after nerve injury. Relative Rest
mRNA levels in neuropathic animals 15 days postinjury displayed
large variability, but by 30 days Rest mRNA levels in ipsilateral
DRG of neuropathic rats reached the level of 0.02 ± 0.004 (n = 8),
which was signiﬁcantly higher than the levels in naïve rats or sham
controls (0.004 ± 0.001, n = 7 and 0.008 ± 0.002, n = 6; P < .05)
(Fig. 7B). In line with the case of Kcnq2, there was a tendency forRestmRNA to increase in the contralateral DRG of PSNL rats as well,
but it did not reach signiﬁcance (P = .13). In summary, there was a
general tendency for Kcnq2 mRNA levels to decrease and for Rest
mRNA to increase in both ipsilateral and contralateral L4/L5 DRG
after the PSNL injury. However, only the ipsilateral DRG showed
signiﬁcant changes in the expression of these genes.
To test whether the expression of Rest and Kcnq2 mRNA is mir-
rored by the appropriate changes in protein levels, we performed
immunohistochemical analysis. First, we characterized expression
of REST protein in DRG. Using antibodies against REST, neuronal
nuclei marker NeuN (Fig. 8), or satellite glial cell (SGC) marker
GFAP (Fig. 9), we found low but distinct REST immunoreactivity
within the DRG neuron nuclei and almost no expression in SGC.
We then evaluated changes in Kv7.2 and REST expression after
the PSNL using immunohistochemistry and Western blot. Consis-
tent with our RT-PCR data, Kv7.2 immunoreactivity was markedly
Fig. 8. Expression of REST in DRG neurons. Confocal micrographs for immuno-
staining with antibodies against REST (a); the neuronal nuclei marker NeuN (b);
DAPI nuclear staining (c); no-primary control (d) and co-staining with REST, NeuN,
and DAPI (e). Scale bars = 50 lm.
Fig. 9. Lack of REST expression in satellite glial cells (SGC). Confocal micrographs
for immunostaining with antibodies against REST (a); the glial cell marker GFAP (b);
DAPI staining of glial and neuronal nuclei (c); no-primary control (d) and co-
staining with REST, GFAP, and DAPI (e). Scale bars = 50 lm.
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staining for Kv7.2 in the ipsilateral DRG can be seen even 15 days
after surgery (compared with sham controls), and by 30 days the
reduction was prominent (Fig. 10A). Changes in Kv7.2 staining at
the contralateral DRG of the PSNL animals were not dramatic. Sim-
ilarly, REST protein abundance also increased dramatically in the
nuclear-enriched fraction of the whole-DRG lysates from ipsilateral
L4/L5 of PSNL rats as compared with samples from naive or sham
controls (Fig. 10B and C). In accord with reported low expression
of REST in the CNS (particularly in forebrain [34]), REST immunore-
activity was detected within kidney tissue but not in forebrain
(Fig. 10D). Successful fractionation of the DRG lysates into nuclear
and cytosolic fractions was assessed by b-actin (predominantly
cytosolic protein) and Nup62 (nuclear membrane protein) immu-
noreactivity (Fig. 10E).
3.3. Local injection of M channel opener to injury site caused a
decrease in thermal hyperalgesia
Recent reports demonstrated that inhibition of M channel activ-
ity at the peripheral nerve terminals of the sciatic nerve is, on itsown, sufﬁcient to cause overexcitability and pain [25,26]. More-
over, M current inhibition by such inﬂammatory mediators as bra-
dykinin [26] or proteases [25] contributes to DRG excitability and
hyperalgesia. Importantly, M channel opener retigabine reversed
bradykinin-induced M channel inhibition (when applied to dissoci-
ated DRG neurons) and alleviated bradykinin-induced hyperalgesia
(when injected into the hind paw) [26]. In addition, it was shown
that systemic administration of retigabine alleviated neuropathic
pain [12], whereas direct retigabine application to axotomised
afferents reduced their excitability [40].
According to the data presented here, M channel abundance
within lumbar DRG decreases signiﬁcantly after PSNL. Therefore,
we tested whether some of the neuropathic pain symptoms could
be attenuated by peripheral augmentation of M channel activity.
First, we evaluated the development of thermal (Fig. 11A) and
mechanical (Fig. 11B) hyperalgesia following the PSNL at time
intervals matching our previous studies. PSNL rats exhibited uni-
lateral thermal hyperalgesia at the ipsilateral hind paw and also
exhibited mechanical hyperalgesia, which was unilateral 15 days
after injury and became bilateral by 30 days (Fig. 11A and B).
The original report of the PSNL model [43] described mirror
Fig. 10. Reciprocal changes in the expression of Kv7.2 and REST proteins after peripheral nerve injury. (A) Confocal micrographs of DRG sections stained with anti-Kv7.2
antibody from 15 days (left 4 panels) and 30 days (right 4 panels) postsurgery PSNL or control (sham) animals. Scale bar = 50 lM. (B) Western blots of the nuclear-enriched
fraction of DRG lysates from sham, PSNL (30 days after injury), and naive animals using anti-REST (REST) antibody and anti-Nup 62 (Nup 62). (C) Protein levels were
quantiﬁed and REST levels normalised to the levels of Nup 62. Differences were analysed using one-way analysis of variance Holm–Sidak multiple comparison test, (⁄P < .05,
naïve n = 3, sham and PSNL n = 8). (D) Western blots of proteins extracted from kidney and forebrain probed with anti-REST and anti-Nup 62 antibody. (E) Western blot of
proteins from total, cytosolic, and nuclear fractions from DRG probed with b-actin and anti-Nup 62 antibodies.
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paw; however, the lack or delayed bilaterality has been reported
by others [4,22]. In the present study we observed consistent
mechanical and thermal hyperalgesia on the ipsilateral paw and
delayed mechanical hyperalgesia on the contralateral paw.
To probe whether pharmacological M channel augmentation
within the injured nerve ﬁbres would alleviate PSNL-induced
hyperalgesia, we looked for a protocol that would allow manipula-
tion of M channel activity at the site of neuroma. Hind paw injec-
tions of M channel drugs would not be the best approach because
in PSNL ligated ﬁbres are cut below the ligature site and degener-
ate. On the other hand, it has been suggested that the neuropathic
hyperalgesia after the peripheral nerve lesion is maintained by
central sensitization within the spinal cord resulting from the con-
stant input from the ectopic afferent discharge from the site of
peripheral nerve injury [16,44,47]. This central sensitization ampli-
ﬁes the input from uninjured ﬁbres resulting in hyperalgesia.
Accordingly, local application of low doses of lidocaine speciﬁcallyto injured ﬁbres in the SNL model of neuropathic pain alleviated
hypersensitivity of intact ﬁbres [47]. We reasoned that pharmaco-
logical restoration of M channel function by injecting M channel
opener directly into the perisciatic nerve (PSN) space surrounding
neuroma (Fig. 12A) may dampen the ectopic ﬁring from neuroma
and alleviate the neuropathic hyperalgesia by way of reducing
spinal sensitization. To test whether we indeed can deliver drugs
directly to the injured sciatic nerve, we injected lidocaine (200 lL
of 0.65% v/v) directly into neuroma, which produced a transient
(approximately 2 minutes) period of paralysis followed by a
marked increase in thermal latency of the ipsilateral hind paw
withdrawal in PSNL rats (Fig. 12B), conﬁrming the accuracy of
PSN injection. We then injected the M channel opener ﬂupirtine
(chemical analogue of retigabine) to test its effects on neuropathic
hyperalgesia. PSN injection of ﬂupirtine (200 lL, 10 nmole/site)
into the neuroma site of rats 30 days after injury signiﬁcantly in-
creased hind pawwithdrawal latency in the ipsilateral paw of PSNL
animals, whereas such injections were without signiﬁcant effect
Fig. 11. Behavioural analysis of PSNL animals. (A) Thermal hyperalgesia measured
as the hind paw withdrawal latency (see Section 2) at baseline and 15 and 30 days
postsurgery of the ipsilateral and contralateral paws form control and PSNL rats;
nP 11; Kruskal–Wallis one-way analysis of variance on ranks with Dunn’s multiple
comparison test (⁄P 6 .05). (B) Mechanical hyperalgesia as the hind paw withdrawal
threshold (see Section 2) at baseline and 15 and 30 days postsurgery of the
ipsilateral and contralateral paws form control and PSNL rats; nP 11; Kruskal–
Wallis one-way analysis of variance on ranks with Dunn’s multiple comparison test
(⁄P < .05).
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sciatic nerves in sham controls (Fig. 12C through F). Importantly,
the effect of ﬂupirtine was completely blocked by co-injection of
XE991 (200 lL, 2 nmole/site; Fig. 12D). Consistent with our
hypothesis, XE991 injected alone did not affect paw withdrawal la-
tency in either of the experimental conditions. In an uninjured paw
(contralateral PSNL, sham and naive rats), peripheral nerve endings
within the plantar surface of the paw are the sole source of excita-
tion in response to stimuli applied to the plantar paw, an area that
was not affected by the injection (Fig. 12A). In the injured paw, the
neuroma site provides an additional source of activity, but because
of the decreased level of Kcnq2 expression, the tonic M channel
activity must be very low and additional M channel inhibition
has no further effect. However, by activating the M channels that
are present, the M channel opener reinstates M current levels
and thus reduces thermal hyperalgesia to almost basal level (com-
pare Fig. 11A and Fig. 12C). In summary, the behavioural tests sup-
ported our hypothesis that M channel activity within the
peripheral nerves controls the ﬁbre excitability and that decreased
M current may contribute to hyperalgesia; furthermore, we dem-
onstrated that pharmacological targeting of peripheral M channels
is efﬁcacious against neuropathic hyperalgesia.
4. Discussion
We investigated functional expression in sensory neurons of the
Kcnq2 gene encoding the K+ channel subunit Kv7.2, which forms
membrane potential stabilizing M channels. We found that Kv7.2
is expressed in a large number of small nociceptive neurons, many
of which also expressed the nociceptive markers IB4 and TRPV1,
whereas only a small number of larger, NF200-positive neurons
were Kv7.2-positive. Although precise measurement of colocaliza-tion of immunoreactivities is difﬁcult and there is always some de-
gree of colocalization by chance, our conclusion that Kv7.2 is
predominantly expressed in small nociceptive neurons is sup-
ported by the size distribution of the Kv7.2-positive neurons
(Fig. 1B). Furthermore, previous studies have reported that approx-
imately 30% of small sensory neurons are IB4 positive [3] and
approximately 50% of small to medium DRG neurons are TRPV1po-
sitive [17]. These proportions are similar to that for the percentage
of Kv7.2-positive neurons that are IB4 or TRPV1 positive. We
hypothesize that the higher levels of M channel expression in noci-
ceptors as compared with other sensory neurons may underlie the
higher threshold for action potential ﬁring of nociceptors [31]. M
channel activity provides an intrinsic voltage clamp mechanism
allowing neurons to stabilize the resting membrane potential at
voltages near the M channel activation threshold [7]. Therefore, a
high level of functional M channel expression results in a neuron
with reduced excitability (as was directly shown for sympathetic
neurons [21]).
M channel inhibition in nociceptive neurons was shown to in-
crease their excitability and was sufﬁcient to induce a moderate le-
vel of pain [25,26]. We therefore hypothesized that long-term
downregulation of the M channels may contribute to hyperexcit-
ability of sensory ﬁbres in neuropathic injury. Indeed, we observed
strong downregulation of Kv7.2 in the ipsilateral DRG of the rats
with PSNL. This downregulation correlated with an increase of
the mRNA and protein levels of REST, which negatively regulates
Kcnq gene expression (eg, transient overexpression of REST in
DRG suppressed Kcnq2 expression, reduced M current density,
and produced highly excitable nociceptive neurons [32]). Impor-
tantly, other Kcnq genes expressed in DRG, Kcnq3 and Kcnq5, can
also be suppressed by REST [32]; therefore, stimulation of REST
expression in neuropathic neurons should result in general down-
regulation of all M channels. We further hypothesize that REST
expression in sensory neurons is induced by trauma and/or inﬂam-
mation (as suggested in Mucha et al. [32]) accompanying the onset
of neuropathic injury. Indeed, increase of REST expression in sen-
sory neurons days after the neuropathic injury has been reported
[49], and in our study we saw a tendency for Rest upregulation at
15 days postinjury and further signiﬁcant upregulation at 30 days
(when signiﬁcant decrease of Kcnq2 expression was observed).
Importantly, the efﬁciency of transcriptional suppression of target
genes by REST depends on the REST afﬁnity of the individual RE1
sites and from REST concentration [33]. Therefore, we suggest that
gradual increase of Rest expression after nerve injury can cause a
successive knock-down of its target genes in accordance with the
strength of interaction between REST and its discrete binding sites.
Noteworthy is the fact that neuropathic pain-associated suppres-
sion of several REST target genes has been demonstrated; these in-
clude genes encoding the K+ channels Kv4.3 [50] and Kv3.4 [8], the
Na+ channel Nav1.8 [49], and the l-opioid receptor [49,53]. Future
research is needed to correlate the timing of the changes in REST
target gene expression after the nerve injury with the afﬁnity of
their REST binding sites.
Changes of neuronal mRNA and protein levels measured using
whole DRG lysates may be the result of neuronal death or prolifer-
ation of SGC, indeed both effects would not be surprising after an
injury. However, because within DRG, both Kcnq2 and Rest are pre-
dominantly expressed in neurons (Figs. 1C, 8, and 9), a signiﬁcant
decrease in the neuron/glia ratio would result in a simultaneous
decrease of both gene products, which was not the case as Rest
mRNA and protein levels increased while those of Kcnq2 decreased.
In addition, we performed retrograde staining of cell bodies of
damaged ﬁbres at the time of PSNL surgery (data not shown) that
demonstrated that between 15 and 30 days after PSNL there was
no noticeable neuronal death. SGC proliferation in DRG does occur
after nerve injury; however, several studies reported that there
Fig. 12. Perisciatic nerve injection of M channel opener alleviated thermal hyperalgesia produced by PSNL. (A) Schematic representation of the perisciatic nerve injection;
injured nerve with neuroma is depicted in red. (B) Perisciatic nerve injection of lidocaine caused a decrease in thermal hyperalgesia in PSNL animals, conﬁrming accuracy of
sciatic nerve injection method. Neuroma site of PSNL rats was injected with 200 lL of 0.65% lidocaine solution, which caused a decrease in thermal hyperalgesia as compared
with vehicle. (C–F) Hind paw withdrawal latency measured in PSNL (C and D) and sham (E and F) rats for ipsilateral (C and E) and contralateral (D and F) paws in response to
injections of vehicle, ﬂupirtine (200 lL, 10 nmol/site), XE991 (200 lL, 2 nmol/site) or ﬂupirtine and XE991. All experiments in B through F were performed 30 days after the
surgery; site of injection is depicted in (A). ⁄P < .05; one-way analysis of variance with Dunn’s multiple comparison procedure (nP 4).
752 K. Rose et al. / PAIN

152 (2011) 742–754may be 2 waves of such proliferation. The ﬁrst wave starts imme-
diately after injury with glial cell number returning to the baseline
by the end of the ﬁrst week (this most likely is an inﬂammatory
process [20]); the second wave is characterized by formation of
‘‘onion bulbs’’—DRG neuron somata wrapped in multiple SGC lay-
ers [45], however, this process is not apparent until the 5th week
after injury and was not seen in any DRG sections in this study. Be-
cause our experiments were performed at 15 and 30 days after in-
jury, it is possible that this period falls between 2 waves of SGC
proliferation.
Neuronal population of L4 and L5 DRG in PSNL animals is com-
prised of axotomised and intact neurons. Although we did not spe-
ciﬁcally test whether these neuronal subpopulations responded
differently in terms of Kcnq2 and Rest expression, our data suggest
that there is rather a global effect of partial axotomy on the expres-
sion of these genes in DRG (eg, Fig. 10A). In addition, our data sug-
gest that hyperalgesia in PSNL animals appears sooner than the
Kcnq2 downregulation occurs; thus signiﬁcant downregulation of
Kcnq2 was only detected at 30 days postinjury (Fig. 7A), whereas
the hyperalgesia was already developed by 15 days (Fig. 11).Although immunohistochemistry (Fig. 10A) suggests that there
is some downregulation of Kv7.2 in DRG of PSNL animals at 15
days postinjury (which may reﬂect poor sensitivity of the RT-
PCR analysis), the fact that hyperalgesia is already fully devel-
oped by 15 days whereas Kcnq2 downregulation is not suggests
that the Kcnq2 downregulation is a delayed feature of nerve in-
jury that is developed in response to the initial hyperexcitability
produced by other factors. It is conceivable that the initial
hyperexcitability of peripheral ﬁbres after the injury is driven
by more acute factors such as trauma and inﬂammation (to
which acute inﬂammatory inhibition of M channel activity most
likely contributes [25,26]); therefore, the transcriptional mecha-
nism described here may have a role in the maintenance of pain
rather than in its initiation. The injury-induced inﬂammation is
likely to affect both axotomised and intact ﬁbres within the af-
fected nerve, and we recently presented evidence that inﬂamma-
tory excitation triggers Rest expression in DRG neurons, which in
turn causes downregulation of Kcnq2 [32]. Thus, it is logical to
expect some global decrease in REST target gene expression after
partial axotomy, although the severed ﬁbres will most likely be
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hypothesis is correct.
To test the role of M channel regulation in neuropathic pain
in vivo, we used a behavioural paradigm. In accord with previous
ﬁndings suggesting that augmentation of M current in sensory ﬁ-
bres has an antinociceptive effect [6,18,24,40], we demonstrated
that thermal hyperalgesia produced by neuropathic injury is allevi-
ated by PSN injection of the M channel opener ﬂupirtine, an effect
that was completely blocked by the M channel blocker XE991.
Interestingly, PSN injections of ﬂupirtine did not affect thermal
withdrawal latencies in uninjured paws. Although the site of injec-
tion in our experiments did not encompass the site of stimulation
(Fig. 12A), one can expect that PSN injection of M channel opener
could hyperpolarize the area of the nerve and to some extent block
action potential propagation. It was suggested that the membrane
potential in sympathetic and sensory neurons can be set by a dy-
namic equilibrium of 2 opposing currents, depolarizing Ih (hyper-
polarization-activated current conducted by HCN channels) and
hyperpolarizing IM; with Ih being activated at the potentials nega-
tive to 50 mV and IM activating at potentials positive to 60 mV
[1,23]. Thus, we speculate that the lack of any signiﬁcant effect of
M channel augmentation on uninjured paws may result from the
offsetting action of Ih. In contrast, when M channel abundance is
decreased and the ﬁbre is tonically depolarised, activation of resid-
ual M channels results in reversion of depolarization back to the le-
vel at which Ih starts coming into play, which results in a reset of an
overexcitable neuron into a low-excitability state manifested in
the increase of hind paw withdrawal latency (Fig. 12C).
There are reports of sympathetic sprouting and proliferation
after PSNL injury resulting in sympathetically maintained pain
[46]. Further, it was suggested that the central analgesic action of
ﬂupirtine is via alterations in descending sympathetic tone [48].
Although the injected dose of ﬂupirtine was too low to cause a sig-
niﬁcant central effect, it cannot be excluded that alterations in
Kv7.2 expression within sympathetic postganglionic neurons
and/or alterations in sympathetic tone contributed to the analgesic
effect of ﬂupirtine reported here.
In conclusion, we have identiﬁed a novel transcriptional mech-
anism that may contribute to the neuropathic overexcitability of
peripheral sensory ﬁbres: the downregulation of the Kcnq2 gene
encoding the M channel subunit Kv7.2 by REST. Our data identify
M channels and REST as peripheral targets for treatment of pain.Acknowledgements
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